ProMIS Neurosciences commends Biogen for clarifying aducanumab regulatory filing
Go back to ProMIS Neurosciences commends Biogen for clarifying aducanumab regulatory filing| Amorfix Life Sciences Ltd Common Shares (AMEX: ARFXF) | Delayed: 0.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.10 | 52 Week High | $0.16 | |||
| Open | $11.33 | 52 Week Low | $0.03 | |||
| Day High | $0.10 | P/E | N/A | |||
| Day Low | $0.10 | EPS | $0.00 | |||
| Volume | 3,285 | |||||
| Imperial Petroleum, Inc. (NASDAQ: PMN) | Delayed: 14.50 -0.47 (3.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.97 | 52 Week High | $0.05 | |||
| Open | $15.00 | 52 Week Low | $0.05 | |||
| Day High | $15.00 | P/E | N/A | |||
| Day Low | $14.10 | EPS | $0.00 | |||
| Volume | 12,827 | |||||
